Science Explorer Back to mapMap
Discussion
Researcher · Actelion (Switzerland) · Switzerland

Hans H. Locher

Hans H. Locher publishes mostly in Infectious Diseases, Molecular Biology and Organic Chemistry, on topics such as Antibiotic Resistance in Bacteria, Clostridium difficile and Clostridium perfringens research and Antimicrobial Peptides and Activities.

OpenAlex
World rank
#811,719
of 7,710,434 ranked researchers
Rank in Switzerland
#14,268
of 80,918
Works
47
Citations
2.2k
Citations per work
46.8
h-index
26
i10-index 34Top 14% in Infectious Diseases
Hans H. Locher

What does Hans H. Locher research?

Hans H. Locher's work is mostly in Biochemistry, Genetics and Molecular Biology (21%), Medicine (20%), Chemistry (12%).

Everything else: 18 works · 39.1% of their workLife Sciences: 10 works · 21.1% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 21.1% of their workMolecular Biology: 6 works · 13.8% of their workMolecular Medicine: 3 works · 7.3% of their workHealth Sciences: 10 works · 20.3% of their workMedicine: 10 works · 20.3% of their workInfectious Diseases: 7 works · 15.4% of their workEpidemiology: 2 works · 4.9% of their workPhysical Sciences: 9 works · 19.5% of their workChemistry: 6 works · 12.2% of their workOrganic Chemistry: 6 works · 12.2% of their workEnvironmental Science: 3 works · 7.3% of their workPollution: 3 works · 7.3% of their workTHEIR WORKHans H. Locher47works
Life Sciences21%Physical Sciences19%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1839.1%
    1. Biochemistry, Genetics and Molecular Biology1021.1%
    1. Medicine1020.3%
    1. Chemistry612.2%
    2. Environmental Science37.3%
  1. 1Infectious Diseases15% of their works
  2. 2Molecular Biology14% of their works
  3. 3Organic Chemistry12% of their works
  4. 4Pollution7% of their works
  5. 5Molecular Medicine7% of their works
  6. 6Epidemiology5% of their works

Research topics

Which keywords describe Hans H. Locher's research?

The keywords of their largest research topics: Epidemiology, Healthcare-Associated Infections, Antibiotic Resistance, Antibiotic-Associated Diarrhea, Fecal Microbiota Transplantation, Multidrug-Resistant Bacteria, Antimicrobial Peptides and Host Defense.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Epidemiology142 topics
  2. Healthcare-Associated Infections142 topics
  3. Antibiotic Resistance91 topic
  4. Antibiotic-Associated Diarrhea91 topic
  5. Fecal Microbiota Transplantation91 topic
  6. Multidrug-Resistant Bacteria91 topic
  7. Antimicrobial Peptides51 topic
  8. Host Defense51 topic
  9. MRSA51 topic
  10. Staphylococcus aureus51 topic
  11. DNA41 topic
  12. Fibroblast Activation Protein41 topic
  13. Heterocyclic Compounds41 topic
  14. Medicinal Chemistry41 topic
  15. Pesticides41 topic
  16. Pollution41 topic
  17. Topoisomerases41 topic
  18. Tumor Microenvironment41 topic

Where does Hans H. Locher work?

Hans H. Locher's main affiliation in the publication record is Actelion (Switzerland), Switzerland.

How many publications and citations does Hans H. Locher have?

OpenAlex counts 47 works and 2,201 citations for Hans H. Locher, an h-index of 26, ranking #811,719 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hans H. Locher. Posts are plain text and can be reported.